Search for: "Acorda Therapeutics, Inc." Results 1 - 20 of 49
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
26 Jan 2016, 11:23 am by Lawrence B. Ebert
**As one small footnote, Ampyra is not a disease-modifying treatment for MS, in contrast to Copaxone or Tecfidera.link to BNA report: http://www.bna.com/acorda-par-settle-n57982066522/ [read post]
25 Aug 2015, 9:09 am by Gene Quinn
The USPTO declined to initiate an inter partes review of two patents owned by Acorda Therapeutics, Inc. [read post]
15 Jul 2011, 2:10 pm
NY-based Acorda Therapeutics, Inc. has licensed worldwide development and commercialization rights to a proprietary magnesium formula (referred to as AC105) from Medtronic, Inc. [read post]
21 Mar 2015, 6:26 am by Lawrence B. Ebert
Del; Acorda Therapeutics, Inc. v. [read post]
18 Oct 2016, 8:23 pm by Kate Howard
Acorda Therapeutics Inc. 16-360 Issue: Whether the mere filing of an abbreviated new drug application by a generic pharmaceutical manufacturer is sufficient to subject the manufacturer to specific personal jurisdiction in any state where it might someday market the drug. [read post]
15 Apr 2019, 6:09 am by Matthew L.M. Fletcher
Teva Pharmaceuticals USA Inc.: Allergan & SRMT Cert Petition Questions presented: Whether the Federal Circuit erred in this case, as it did in Acorda Therapeutics, Inc. v. [read post]
24 Aug 2015, 5:37 pm by Lawrence B. Ebert
Acorda Therapeutics, IPR2015-00720 and IPR2015-00817, U.S. [read post]
29 Jul 2014, 9:11 pm by Patent Docs
Acorda Therapeutics Inc. v. [read post]
10 Sep 2018, 10:17 am by Lawrence B. Ebert
Acorda Therapeutics, Inc. v.Roxane Labs., Inc., No. 1:14-cv-00882-LPS, 2017 WL1199767, at *3, *5 (Mar. 31, 2017) (Dist. [read post]
18 Mar 2016, 2:04 pm
  The federal circuit’s decision came down today in Acorda Therapeutics Inc. v. [read post]
30 Sep 2019, 9:02 am by Dennis Crouch
  The court is scheduled to consider whether to grant certiorari in a number of important patent cases: Obviousness: Acorda Therapeutics, Inc. v. [read post]